ArticlePDF Available

Anti-inflammatory Effects of Violaxanthin Isolated from Microalga Chlorella ellipsoidea in RAW 264.7 Macrophages

Authors:

Abstract and Figures

Violaxanthin is a major carotenoid of microalgae Chlorella ellipsoidea and is also found in dark-green leafy vegetables, such as spinach. In this study, the anti-inflammatory effect of violaxanthin isolated from C. ellipsoidea was examined using lipopolysaccharide (LPS)-stimulated RAW 264.7 mouse macrophage cells. In addition, the anti-inflammatory activity and mechanism of action of purified violaxanthin was assessed using various assays, such as quantitative real-time polymerase chain reaction (PCR), Western blotting, and electrophoretic-mobility shift assay (EMSA). The results of this combined analysis revealed that violaxanthin significantly inhibited nitric oxide (NO) and the prostaglandin E₂ (PGE₂). Interestingly, violaxanthin effectively inhibited LPS-mediated nuclear factor-κB (NF-κB) p65 subunit translocation into the nucleus, suggesting that the violaxanthin anti-inflammatory activity may be based on inhibition of the NF-κB pathways. In conclusion, violaxanthin of C. ellipsoidea holds promise for use as a potential anti-inflammatory agent for either therapeutic or functional adjuvant purposes.
Content may be subject to copyright.
July 2012 1137Biol. Pharm. Bull. 35(7) 1137–1144 (2012)
© 2012 The Pharmaceutical Society of Japan
Anti-inammatory Effects of Violaxanthin Isolated from Microalga
Chlorella ellipsoidea in RAW 264.7 Macrophages
Waesarat Soontornchaiboon,a,# Seong Soo Joo,b,# and Sang Moo Kim*,a
a Department of Marine Food Science and Technology, Gangneung-Wonju National University; and b Department of
Marine Molecular Biotechnology, Gangneung-Wonju National University; 120 Gangneung Daehangno, Gangneung,
Gangneung 210–702, Republic of Korea. Received February 23, 2012; accepted April 23, 2012
Violaxanthin is a major carotenoid of microalgae Chlorella ellipsoidea and is also found in dark-green
leafy vegetables, such as spinach. In this study, the anti-inammatory effect of violaxanthin isolated from C.
ellipsoidea was examined using lipopolysaccharide (LPS)-stimulated RAW 264.7 mouse macrophage cells.
In addition, the anti-inammatory activity and mechanism of action of puried violaxanthin was assessed
using various assays, such as quantitative real-time polymerase chain reaction (PCR), Western blotting, and
electrophoretic-mobility shift assay (EMSA). The results of this combined analysis revealed that violaxanthin
signicantly inhibited nitric oxide (NO) and the prostaglandin E2 (PGE2). Interestingly, violaxanthin effec-
tively inhibited LPS-mediated nuclear factor-κB (NF-κB) p65 subunit translocation into the nucleus, suggest-
ing that the violaxanthin anti-inammatory activity may be based on inhibition of the NF-κB pathways. In
conclusion, violaxanthin of C. ellipsoidea holds promise for use as a potential anti-inammatory agent for
either therapeutic or functional adjuvant purposes.
Key words anti-inammation; Chlorella ellipsoidea; microalgae; violaxanthin; RAW 264.7 cell; nuclear
factor-κB p65
Inammation is the normal physiological and immune
response to tissue injury and occurs when the human body
attempts to counteract potentially injurious agents, such as
invading bacteria, vir uses, and other pathogens.1) Among im-
mune cells, macrophages play important roles in inammation
by overproducing inammatory mediators, including nitric ox-
ide (NO) and prostaglandin E2 (PGE2), which are synthesized
by inducible nitric oxide synthase (iNOS) and cyclooxygenase
(COX-2), respectively.2) Since inammatory mediators can
cause severe damage, such as sepsis and inammatory dis-
eases, inhibiting NO and PGE2 production by blocking iNOS
and COX-2 at the molecular may be a useful strategy for the
treatment of acute or chronic inammatory disorders.3,4)
Importantly, iNOS is highly expressed in macrophages and
can lead to organ destruction in some inammatory and auto-
immune diseases.5) PGE2 is another important inammatory
mediator and is produced from arachidonic acid metabolites
by the catalysis of cyclooxygenase-2 (COX-2).2,6) During
inammation, macrophages play a central role in managing
many different immunopathological phenomena, including the
overproduction of pro-inammatory mediators, such as NO
and PGE2. Experimentally, lipopolysaccharide (LPS) and pro-
inammatory cytokines activate immune cells to up-regulate
inammatory states, and these are therefore useful targets
in the development of anti-inammatory agents and for the
exploration of molecular anti-inammatory mechanisms.7,8) In
cell signal pathways, nuclear factor-κB (NF-κB) is known to
stimulate the expression of enzymes, such as inducible iNOS
and COX-2, and recent studies have identied that the toll-like
receptor 4 (TLR4) is a signal-transducing receptor for LPS.9)
LPS also directly activates the NF-κB pathway via TLR4 that
amplies the inammatory responses by establishing a posi-
tive autoregulator y loop.10)
A seawater microalga, Chlorella ellipsoidea, which contains
a high content of carotenoids, is commonly used as feed for
marine shes. C. ellipsoidia, is photosynthetic organism con-
taining biologically active compounds, such as carotenoids,
phycobilins, fatty acids, polysaccharides, vitamins, and ste-
rols.11) The carotenoids from microalgae function as acces-
sory pigments in photosystems and str uctural components of
light harvesting complexes, as well as photoprotective agents,
which play roles in phototaxis.12,13) Various microalgae ac-
cumulate large quantities of carotenoids, which have been
exploited commercially, including β-carotene from Dunaliella,
astaxanthin from Haematococcus, and lutein from Chlorophy-
cean strains.14–16) C. ellipsoidea is abundant and commonly
used for marine sh and brine shrimp hatcheries in Japan and
Korea.17) There has been only one report that examined the
antiproliferative effect of carotenoids from C. ellipsoidea on
human colon cancer cells.18) The main carotenoid from ma-
rine C. ellipsoidea was found to be violaxanthin, which also
contains minor amounts of two xanthophylls, antheraxanthin
and zeaxanthin.18) The antioxidant potential of carotenoid is
primarily due to violaxanthin, which is present in orange
colored fruits and green vegetables.19) Violaxanthin from wa-
ter spinach (Ipomoea aquatica) was reported to have a more
potent scavenging ability than lutein and β-carotene in ABTS
radical-scavenging, inhibition of red blood cell hemolysis, and
inhibition of lipid peroxidation in liver.20) However, the poten-
tial anti-inammatory effects of major carotenoids from C.
ellipsoidea have not yet been investigated.
The aim of this study was to investigate the effect of the
major carotenoid isolated from C. ellipsoidea on anti-inam-
matory potencies by evaluating the inhibition of NO, PGE2
production, and the expressions of inducible nitric oxide syn-
thase (iNOS) and cyclooxygenase (COX-2) in LPS-stimulated
RAW 264.7 cells by deter mining the molecular mechanism of
violaxanthin action in LPS-induced NF-κB signaling pathway.
Regular Article
* To whom cor respondence should be addressed. e-mail: smkim@gwnu.ac.kr
The authors declare no conict of interest.
# These authors contributed equally to this work.
1138 Vol. 35, No. 7
MATERIALS AND METHODS
Materials Dimethyl sulfoxide (DMSO), Griess reagent,
Celecoxib, and NG-Methyl-L-arginine acetate salt (L-NMMA)
were purchased from Sigma-Aldrich (MO, U.S.A.). Poly-
merase chain reaction (PCR) primers were purchased from Bi-
oneer (Deajeon, South Korea). All other chemicals used were
of analytical grade.
Preparation of the Microalgae Extract Chlorella ellip-
soidea was obtained from the Daesang company (Seoul, South
Korea). Chlorella cells were harvested from culture solution
by centrifugation at 7000
rpm for 10 min at 4°C and freeze-
dried in a vaccum freezer-dryer (Samwon Freezing Engineer-
ing, Seoul, South Korea). The dried sample was nely ground
in a mortar and stored at 80°C before extraction.
The Chlorella powder (4 g) was extracted with 200 mL of
90% ethanol for 30 min by ultrasound-assisted extraction at a
frequency of 35 kHz (Berlin, Germany) and room temperature,
which was repeated three times. The combined extracts were
ltered through Whatman No. 2 lter paper and saponied
by adding 6% KOH (w/v) (24 g), and then heated at 50°C for
30 min with shaking at 100 r pm. After cooling to room tem-
perature, the mixture was evaporated under vacuum at 40°C.
The ethanol extract was dissolved in distilled water (300 mL),
and then partitioned with ethyl acetate (300 mL) three times.
The concentrated ethyl acetate fraction (300 mL) was washed
several times with distilled water until the water phase was
colorless. After separation, the ethyl acetate fraction was
evaporated on a rotary evaporator at 40°C.
Isolation and Structural Identication of Violaxanthin
The ethyl acetate fraction was subjected to a silica gel col-
umn (2.0×60 cm), which was eluted with hexane (150 mL),
followed by hexane–acetone (7 : 3, v/v) (400 mL). The target
compound fractions were collected based on the spectral
characteristics of violaxanthin, which were examined over a
range of 350–550 nm using a spectrophotometer, by compar-
ing the wavelengths of maximum absorption and spectral
ne structural values (%III/II). In the epoxide test, 10 mL
of 0.1
M HCl was added to a 1 mL ethanolic carotenoid solu-
tion and the absorption maxima were determined using a
spectrophotometer. The puried compound was identied
by liquid chromatography/mass spectrometry (LC/MS) (HP-
1100MSD, Agilent Technologies, CA, U.S.A.) equipped with
an electrospray ionization (ESI). Mass spectra were acquired
over the m/z 400–700 scan range using a 0.1 unit step size.
Ten μL of isolated compound in methanol was injected into
the LC, Eclipse XDB-C18 column (5 µm, 150×46 mm i.d., Wa-
ters, MA, U.S.A.) and eluted using isocratic solvent system,
acetonitrile–methanol–dichloromethane (71 : 22 : 7, v/v), at a
ow rate of 0.5 mL/min. Finally, the structure of the isolated
compound was determined by spectroscopic methods, includ-
ing 1H-NMR and 13C-NMR. 1H and 13C-NMR were recorded
in chloroform-d1 (CDCl3) on a Bruker DRX-600 spectrometer
(Kalsruhe, Germany).
5,6 : 5,6-Diepoxy-5,5,6,6-tetrahydro- β-carotene-3,3-
diol
1H NMR (600 MHz, CDCl3) δH 0.97 [ 2s, 6H, CH3
(16/16)], 1.14 [ 2s, 6H, CH3 (17/17)], 1.18 [ 2s, 6H, CH3
(18/18)], 1.24 [m, 2H, Hax,-C (2/2)], 1.60 [m, 2H, Hax-C
(4/4)], 1.63 [m, 2H, Heq-C (2/2)], 1.92 [2s, 6H, CH3 (19/19)],
1.97 [2s, 6H, CH3 (20/20)], 2.37 [ddd, 2H, Heq-C (4/4),
J=14.2, 5, 1.4 Hz], 3.90 [m, 2H, H-C (3/3)], 5.87 [2d, 2H, H-C
(7/7), J=15.6 Hz], 6.18 [2d, 2H, H-C (10/10), J=11 Hz], 6.25
[2d, 2H, H-C (14/14), J=10 Hz], 6.28 [2d, 2H, H-C (8/8),
J=15.1 Hz], 6.36[2d, 2H, H-C (12/12), J=14.7 Hz], 6.58 [2dd,
2H, H-C (11/11), J=15, 11.5 Hz], 6.62 [m, 2H, H-C (15/15)]
;13C NMR(150 MHz, CDCl3) δC 35.4 (C-1,1), 47.3 (C-2,2),
64.4 (C-3,3), 41.1 (C-4,4), 67.1 (C-5,5), 70.4 (C-6,6), 123.9
(C-7,7), 137.4 (C-8,8), 134.4 (C-9,9), 132.3 (C-10,10), 124.8
(C-11,11), 138.2 (C-12,12), 136.5 (C-13,13), 132.9 (C-14,14),
130.3 (C-15,15), 25.0 (C-16,16), 29.7 (C-17,17), 20.1
(C-18,18), 12.9 (C-19,19), 13.1 (C-20,20).
Cell Culture Raw 264.7 (Mouse leukaemic mono-
cyte macrophage cell line) cells were grown in Dulbeccos
modied Eagles medium (DMEM) (Hyclone, UT, U.S.A.)
supplemented with 10% fetal bovine serum (FBS), 4 mM/L
L-glutamate (Invitrogen, CA, U.S.A.), 100 U/mL penicil-
lin and 100 µg/mL streptomycin (Invitrogen). Cultures were
maintained under 5% CO2 at 37°C in tissue culture asks. In
all experiments, the cells were grown to a conuency greater
than 90% and subjected to no more than 20 cell passages.
Cellular Cytotoxicity (Lactate Dehydrogenase) Assay
The cytotoxicity induced by violoaxanthin was quantitated
by measuring lactate dehydrogenase (LDH) release. The LDH
content was determined using a commercial non-radioactive
LDH assay kit, CytoTox 96® (Promega, WI, U.S.A.), which
was based on a coupled enzymatic reaction that converts tet-
razolium salt into a red formazan product. The increase in the
amount of formazan produced in the culture supernatant di-
rectly correlates with the increase in the number of lysed cells.
The formazan was quantied spectrophotometrically by mea-
suring its absorbance at 490 nm (Spectra Max 340, Molecular
Devices, CA, U.S.A.). Cytotoxicity in experimental samples
was determined as %LDH release compared with cells treated
with 1% Triton X-100.
Nitric Oxide Production in RAW 264.7 Cells RAW
264.7 cells (106 cells/mL) were seeded on a 24-well tissue
culture plate and pre-incubated at 37°C for 12 h to achieve
stable attachment. The wells were then washed with phosphate
buffered saline (PBS) after pre-incubation, refreshed with FBS
free DMEM containing lipopolysaccharide (LPS) (1 µg/mL) in
the presence of different concentrations of violaxanthin (10 to
60 µM) and incubated for 24 h. Nitric oxide (NO) production
was then monitored by measuring nitrite levels in the culture
media using the Griess Reagent at 540 nm (Sigma-Aldrich).
Table 1. Peak Identication of the Puried Compound from Chlorella ellipsoidea and Its Spectral Characteristics Following DAD
Retention time λmax
a) (nm) Hypsochromic shift
(nm) Epoxide test % III/IIb)ESI-MS
(positive, m/z)
Tentative identica-
tion
4.084 417, 441, 470 380, 400, 426 Diepoxide 95 601.4 Violaxanthin
a) The wavelength of maximum absorption. A mobile phase of acetonitrile–methanol–dichloromethane (71 : 22 : 7, v/v) was used. b) Ratio of the height of the longest wave-
length absorption peak, designated III, and that of the middle absorption peak, designated II, taking the minimum between two peaks as baseline, multiplied by 100, in mobile
phase.
July 2012 1139
L-NMMA was compared as a positive control. The concentra-
tion of nitrite (μM) was calculated from a standard curve that
was established using known concentrations of sodium nitrite
dissolved in RPMI-1640 medium.
Prostaglandin E2 (PGE2) Assay The cells (106 cells/
mL) were incubated with LPS (1 µg/mL) in the presence of
violaxanthin at different concentrations (10 to 60 µM) for 24 h
in 24 well-plates. Celecoxib (3 µM) was used as a positive
control. The level of PGE2 in the supernatants from macro-
phage cultures was determined using a competitive enzyme
immunoassay kit (R&D System, MN, U.S.A.) according to the
manufacturers protocol.
Quantitative Real-Time Polymerase Chain Reaction
(PCR) Assay The RAW 264.7 cells were seeded at a density
of 5×106 cells/mL in a 6 well plate and pre-incubated for 12 h.
The cells were then treated with LPS (1 µg/mL) in the absence
or presence of vioaxanthin at different concentrations (10, 30,
60 µM) for 24 h. Total RNAs were prepared from cultured cells
using the Trizol method (Invitrogen). Complementary DNA
(cDNA) was synthesized from ribonucleic acid (RNA) by the
reverse transcription of 1 µg of total RNA using the Improm-II
reverse transcription system and oligo dT primers in a total
volume of 20 µL (Promega, WI, U.S.A.). PCR amplication
was performed using the primers described in Table 2 (Bi-
oneer, Deajeon, South Korea). Quantitative real-time PCR
(qPCR) reactions were run on a Rotor-Gene 6000 (Corbett
Research, Sydney, Australia) using SYBR Green PCR Master
Mix (Qiagen, CA, U.S.A.) in 20 µL reaction mixtures. Each
real-time-PCR master mix contained 10 µL of 2X enzyme
mastermix, 7.0 µL of RNase free water, 1 µL of each primer
(10 pmol each) and 1 µL of diluted template. PCR was per-
formed with an initial pre-incubation step for 10 min at 95°C,
followed by 45 cycles of 95°C for 15 s, annealing at 52°C for
15 s and extension at 72°C for 10 s. Melting curve analysis
was used to conrm formation of the expected PCR product,
and products from all assays were subjected to 1.2% agarose
gel electrophoresis to conrm that the products had the cor-
rect lengths. An inter-run calibrator was used, and a standard
curve was created for each gene to determine PCR efcien-
cies. Relative sample expression levels were calculated using
Rotor-Gene 6000 Series Software 1.7 (Corbett Research, Syd-
ney, Australia), and expressed relative to β-actin and corrected
for between run variability. Data for the experimental samples
were expressed as the percentage of the internal control gene.
Electrophoretic-Mobility Shift (EMSA) Assay (NF-κB
p65) Nuclear extracts for EMSA were prepared from RAW
264.7 cells using Nuclear Extraction Reagents (Pierce, IL,
U.S.A.) according to the manufacturers instructions. EMSA
was performed using the Panomics EMSA kit (Panomics, CA,
U.S.A.). Briey, nuclear extracts containing equal amounts
of proteins for each sample were incubated with poly(dI-dC)
(1 µg/μL) for 5 min, followed by the addition of binding buffer
(20 mM N-(2-hydroxyethyl) piperazine-N´2-ethanesulfonic acid
(HEPES) pH 7.9, 1 mM dithiothreitol (DTT), 0.1 mM ethylene-
diaminetetraacetic acid (EDTA), 50 mM KCl, 5% glycerol and
200 µg/mL bovine serum albumin (BSA) and biotinylated
oligo (10 ng/μL). To control for the specicity of binding for
selected samples, a 5-fold excess of unlabeled oligo was added
prior to the addition of the biotinylated probe. Binding reac-
tion mixtures were incubated for 30 min at room temperature.
Protein–DNA complexes were separated on 6% non-dena-
turing polyacrylamide gels in 0.5×Tris–borate/EDTA buffer
(0.1
M Tris, 0.09 M boric acid containing 1 mM EDTA) at 4°C.
After electrophoresis, the gels were transferred to a positively
charged nylon transfer membrane (Amersham Bioscience, NJ,
U.S.A.). Transferred oligos were immobilized by UV cross-
linking for 10 min. To detect bound oligos, membranes were
blocked using blocking buffer (Panomics EMSA Gel-Shift
Kit). Streptavidin-HRPO was then added and blots were de-
veloped by chemiluminescent detection system according to
the manufacturers instructions (Panomics).
Western Blot Analysis RAW 264.7 cells were lysed in
1% radio immunoprecipitation assay (RIPA) buffer contain-
ing protease and phosphatase inhibitors (Roche, Mannheim,
Germany) and whole cell lysates were separated by 10%
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE). After electrophoresis, proteins were transferred
onto polyvinylidene uoride (PVDF) membranes and the
membranes were blocked with 5% skim milk in Tris-buffered
saline solution containing 0.1% Tween-20. The membranes
were then immunoblotted with primary antibodies, anti-COX2
(Cell Signaling, MA, U.S.A.), anti-iNOS (Cell Signaling),
anti-extracelullar signal-regulated protein kinase, anti-phos-
pho-extracellular signal-regalated kinase (ERK)1/2 (Santa
Cruz Biotechnology, CA, U.S.A.), anti-phospho-inhibitor of
nuclear factor (I)κBα (Santa Cruz Biotechnology) and anti-
actin (Santa Cruz Biotechnology), followed by incubation with
horseradish peroxidase-conjugated anti-rabbit or anti-mouse
secondar y antibodies (Stressgen, CA, U.S.A.). Blots were de-
veloped using an enhanced chemiluminescence (ECL) solution
(Thermo Scientic, IL, U.S.A.)
Statistical Analysis Statistical comparisons between
the groups were performed using one-way analysis of vari-
ance (ANOVA) with a Dunnets post-hoc test, which were
performed using SPSS software (v.13) (IL, U.S.A.). Statistical
signicance was set a priori at p<0.05.
RESULTS
Isolation and Structural Identication of Violaxanthin
Table 2. Primer Sequences Used for Real-Time RT-PCR
Gene Primer Amino acid sequences Product size (bp) Accession No.
iNOS 5 Primer 5- TGCCCCTGGAAGTTTCTCTT-3252 M87039.1
3 Primer 5- ACTGCCCCAGTTTTTGATCC-3
COX-2 5 Primer 5- CCCAGAGCTCCTTTTCAACC-3241 NM_011198
3 Primer 5- AATTGGCACATTTCTTCCCC-3
β-Actin 5 Primer 5- TACAGCTTCACCACCACAGC-3
291 NM_007393
3 Primer 5- AAGGAAGGCTGGAAAAGAGC-3
1140 Vol. 35, No. 7
The ethyl acetate fraction of C. ellipsoidea was further puri-
ed to isolate violaxanthin using silica gel and the target com-
pound fraction was collected based on the absorption spectra.
The visible spectrum characteristics (418, 442, 472 nm) and
spectral ne structural values (% III/II), are presented in Fig.
1A and Table 1, respectively, which were in agreement with
previous reports.21,22) In the epoxide test, a hypsochromic shift
of 40 nm was observed after the addition of HCl, which con-
rmed the presence of two epoxides. The peak purity of viola-
xanthin was determined to be 86% based on the chromato-
graphic purity (Fig. 1B). The mass spectrum corresponding to
the molecular weight of violaxanthin was 600 Da according to
m/z 601 [M+H]+ and fragments at m/z 583 [M+HH2O]+ rep-
resented the elimination of one H2O (Fig. 1C). This compound
was identied as 5,6 : 5,6'-Diepoxy-5,5,6,6'-tetrahydro-β-
carotene-3,3-diol or (all-E)-violaxanthin (Fig. 2) by comparing
its 1H-,13C-NMR with those found in the literature.23–25)
Effect of Violaxanthin on RAW 264.7 Cell Vability and
NO Production The cytotoxic effects of different concentra-
tions of violaxanthin (10–60 µM) on RAW 264.7 cells were de-
termined after incubation for 24 h. In these experiments, vio-
laxanthin did not affect the viability of RAW 264.7 at concen-
trations<100 µM. Hence, the inhibitory effect of violaxanthin
on the LPS-induced RAW 264.7 macrophages was deemed not
to be attributable to cytotoxicity. The effect of violaxanthin
on the cytotoxicity of R AW 264.7 cells was then investigated
over a broader range of concentrations (1 to 250 µM). Incuba-
tion of RAW 264.7 cells with violaxanthin produced a dose-
and time-dependent increase in cell cytotoxicity as measured
by LDH release. Figure 3A shows that violaxanthin concentra-
tions under 100 µM did not signicantly increase LDH release
after exposure for up to 24 h, but a higher concentration
(250 µM) induced a signicant increase in LDH release when
incubated for 24 h. The greatest cytotoxic effect (>90%) was
Fig. 1. Results of HPLC-ESI-MS
(A) Abs orbance spectr a of the puried compound peak recorded in th e high-perform ance liquid chromatography (HPLC) run with a diode array detector; (B), H PLC
prole of viola xanth in f rom C hlorella ellipsoidea; (C), Mass sp ectr um of violaxanthi n f rom C . elli psoidea.
Fig. 2. Chemical Structure of Violaxanthin
July 2012 1141
observed with 250 µM violaxanthin. Because the toxicity with
250 µM violaxanthin was so profound, higher concentrations
were not tested. Based on this result, a violaxanthin concen-
tration below 100 µM was used for further studies.
The potential anti-inammatory properties of violaxanthin
in RAW 264.7 cells after 24 h of treatment with a mixture
of LPS (1 µg/mL) and violaxanthin (10 –60 µM) or LPS (1 µg/
mL) alone (positive control) was examined by adding the
Griess reagent to determine the concentration of nitrites (µM)
in cell super natants. Violaxanthin markedly inhibited the NO
production in LPS (1 µg/mL)-treated RAW 264.7 cells in a
dose-dependent manner (Fig. 3B) and this effect was maximal
at 60 µM (p<0.001).
Effect of Violaxanthin on LPS-Induced PGE2 Produc-
tion The effect of violaxanthin on PGE2 production was ex-
amined in RAW 264.7 macrophages. When the macrophages
were stimulated with LPS (1 µg/mL) for 24 h, the levels of
PGE2 production increased in the culture medium. Treatment
with violaxanthin at different concentrations signicantly in-
hibited PGE2 production (Fig. 4). A dose-dependent effect of
violaxanthin was observed at 30 µM and maximized at 60 µM
(p<0.01 and p<0.001, respectively), which closely corre-
sponded to the positive control, cerecoxib.
Effect of Violaxanthin on the LPS-Induced iNOS and
COX-2 Expression To determine if violaxanthin inhibits
pro-inammator y repertoires (iNOS and COX-2) at the gene
level, RAW 264.7 cells were stimulated by LPS for 24 h and
the expression of iNOS and COX-2 mRNAs was examined
in the presence of varying concentrations of violaxanthin
(10, 30, 60 µM). L-NMMA, an inhibitor of NO generation
Fig. 3. Effect of Violaxanthi n on LPS-Induced NO Production and Cy-
totoxicity in RAW 264.7 Cells
(A) RAW 264.7 cells were ex posed to viola xanth in (1, 10, 50, 100 and 250 µM) for
the indicated times. The concentrat ion depende nt a nd time dependent cytotoxicit y,
measu red as %LDH relea sed into cu lture supern atant, wa s compare d with cells
treat ed wit h 1% Triton X-100. (B) T he NO product ion was assayed fr om the culture
medium of cells stimulate d with LPS (1 µg/mL) in the pr esence of violaxa nthin for
24 h. T he ex periments were perfor med in t riplica te a nd the results are expressed a s
the mean±S.D. ** p<0.01, *** p<0.001 vs. LPS-treate d control group.
Fig. 4. Inhibitor y Effect of Violaxanth in on LPS-I nduced PGE2 Produc-
tion in RAW 264.7 Cells
PGE2 product ion was assayed fro m the cu lture med ium of c ells stimu lated
with LPS (1 µg/m L) i n the pr esence of violaxant hin for 24 h . Each value indicates
the mean±S.D. The experiments were performed in triplic ate and the results are
express ed as the mean±S.D. ** p<0.01 and *** p<0.001 vs. LPS-tr eated cont rol
group.
Fig. 5. Quantitative mR NA Analysis a nd Wester n Blot Proles of iNOS
and COX-2
RAW 264.7 cells were stimulate d with LP S (1 µg/mL) in the absenc e or presence
of violaxanth in for 24 h. L-NMM A or Celecoxib were used as a positive control.
iNOS (A) and COX-2 (B) mRNA and protei n levels were analyzed using Rotor-
Gene 6000 Series Software 1.7 and 10% SDS-PAGE, respectively, as describ ed
in the Materials and Methods. For Wester n bot analysis, 60 µM violaxanth in was
treat ed. The experi ments were perfor med in t riplicate and the results are expresse d
as the mean±S.D. *** indicat es a sig nica nt d iffere nce from the LPS -treat ed con-
trol group (p<0.001).
1142 Vol. 35, No. 7
from arginine, and Celecoxib, a selective COX-2 inhibitor,
were included for comparison.26, 27) The mRNA levels were
assessed using quantitative real-time PCR. As shown in Fig.
5A and 5B, RAW 264.7 cells were highly activated by LPS.
However, the mRNA expression levels for iNOS and COX-2
were signicantly inhibited at violaxanthin concentrations
of 30 and 60 µM and the levels of inhibition were similar to
that produced by L-NMMA (50 µM) or Celecoxib (3 µM) treat-
ment. These results were also observed on the protein level by
Western blot analysis (upper right of each bar graph). These
ndings clearly demonstrate that violaxanthin can effectively
control macrophage-derived pro-inammatory repertoires af-
ter stimulation with LPS.
Inhibition of LPS-Induced NF-κB and ERK1/2 in RAW
264.7 Cells To conrm that violaxanthin might be correlated
with the inhibition of NF-κB and MAPK pathways, we exam-
ined translocation of NF-κB p65 in the cytosol by phosphory-
lation of IκB, followed by binding to specic DNA sequences
in the nucleus, and activation of ERK1/2. This can induce dis-
tinct transcriptional programs leading to macrophages activa-
tion trough LPS stimulation when NF-κB is translocated into
the nucleus, which allows it to bind to specic DNA sequenc-
es. Using immunoblot analysis of NF-κB p65 through the
EMSA supershift assay, we found that viola xanthin (60 µM)
effectively inhibited binding to specic NF-κB p65 DNA
sequences (Fig. 6A). Coincidently, IκBα, which binds to and
inhibits the transcriptional activity of NF-kB, and ERK1/2,
which is increased phosphorylation via LPS stimulation, were
remarkably attenuated in the presence of violaxanthin at 60 µM
(Fig. 6B). Interestingly, these results suggest that violaxanthin
might have an effective anti-inammator y property in mac-
rophages that was comparable to the L-NMMA and celecoxib
controls.
DISCUSSION
In this study, violaxanthin was puried from C. ellipsoidea
and the anti-inammatory effect of violaxanthin on LPS-
induced NO and PGE2 was examined in vitro. The mechanism
of this anti-inammatory effect was also assessed by exam-
ining the expression of iNOS and COX-2 in LPS-stimulated
RAW 264.7 macrophages using qPCR and Western blot analy-
sis. In murine macrophage RAW 264.7 cells, which naturally
express TLR4 complexes, LPS induces iNOS transcription
and transduction with subsequent NO production.28,29) Further-
more, LPS stimulation is known to induce IκB proteolysis and
NF-κB nuclear translocation.30, 31) Therefore, RAW 264.7 cells
provide an excellent model for drug screening and subsequent
evaluation of potential inhibitors of the pathway leading to
iNOS induction and NO production. The reactive free radical
NO, which is synthesized by iNOS, is a major macrophage-
derived inammatory mediator and has also been reported
to be involved in the development of inammator y diseases.
Moreover, a large body of evidence suggests that prostaglan-
dins are involved in various pathophysiological processes,
including inammation and carcinogenesis, and the inducible
cyclooxygenase isoform, COX-2, is mainly responsible for the
production of large amounts of these mediators. Based on this
information, we explored the anti-inammatory activities of
S. micracanthum in LPS-induced NO and PGE2 production in
RAW 264.7 cells as well as NF-κB nuclear translocation. In
the present study, S. micracanthum downregulated the expres-
sion of iNOS and COX-2 proteins and RNA, indicating that
effects of S. micracanthum occur at the transcriptional level.
NO and PGE2 are produced by NOS and COX-2, respec-
tively, which are pro-inammatory mediators involved in
the development of inammatory human diseases.32) Com-
monly, NO plays an important role as an immune regulator
and neurotransmitter in a variety of tissues at physiological
concentrations.33) Overproduction of NO derived from iNOS
plays an important role in the pathogenesis of inamma-
tion.34) On the other hand, PGE2 is a pleiotropic mediator
that causes pain, swelling, and stiffness.35) Hence, inhibitors
of NO and PGE2 production could be used as potential anti-
inammatory agents. The results of this study demonstrated
that violaxanthin inhibited the production of NO and PGE2 in
a dose-dependent manner in RAW 264.7 cells. The effect of
violaxanthin on NO and PGE2 production was consistent with
the carotenoids, where β-carotene, lutein, and fucoxanthin
were shown to suppress NO production.36–38) Violaxanthin
concentrations of 30 and 60 µM signicantly inhibited LPS-
induced NO production by RAW 264.7 cells. At 60 µM, viola-
xanthin signicantly inhibited NO production by as much as
L-NMMA. Coincidently, iNOS mRNA and protein expression
were also signicantly down-regulated. Moreover, violaxan-
thin reduced PGE2 production and expression of COX-2 at the
mRNA and protein level.
Fig. 6. Electrophoretic-Mobilit y Shif t Assay for NF-κB p65 and West-
ern Blot Proles of Phosphorylated IκB and ERK
(A) LPS -stimu lated RAW 264.7 cells were t reated with violaxanthin (60 µM) and
L-NMM A (50 µM) for 6 0 m in, followed by preparation of nuclear extracts for EMSA
as described in t he Ma terial s an d Met hods. Lane 1, lab eled E MSA pr obe only w ith
untre ated sample. La ne 2, labeled EMSA probe w ith L-N MMA-t reated sample.
Lanes 3, lab eled EMSA probe with violaxanthi n. La ne 4, labeled EMSA pr obe wit h
LPS alone. (B) Analysis of phos phor-IκBα and -ER K in lysates of LPS-st imulated
RAW 264.7 cells after 6 h tr eatment . L-N MMA was used as a po sitive c ontrol.
July 2012 1143
TLRs are essential for innate host defense as well as for
controlling adaptive immune responses. Of these, TLR4 plays
an important role in activating NF-κB of LPS-stimulated
macrophages, followed by up-regulation of iNOS and COX-2
expression.39) At the molecular level, we investigated if viola-
xanthin appreciably suppressed the synthesis of iNOS and
COX-2 by inhibiting NF-κB nuclear translocation. NF-κB
activation can induce the overexpression of pro-inammatory
genes in the nucleus, thereby initiating the inammatory pro-
cesses. Interestingly, violaxanthin was shown to inhibit activa-
tion of NF-κB in LPS-activated RAW 264.7 cells in the gel
shift assay (EMSA). Coincidently, violaxanthin well inhibited
phosphorylation of ERK and IκBα, which induce the activa-
tion of LPS-dependent NF-κB and mitogen-activated protein
kinase (MAPK). These experimental ndings suggest that
violaxanthin may exert its inhibitory effects on inammation
by inhibiting the activation of NF-κB, followed by a reduction
in iNOS and COX-2 expression.
Several previous studies have reported that antioxidants,
such as β-carotene and astaxanthin, can inhibit NF-κB activ-
ity and suppress the expression of pro-inammatory genes
as well as production of NO and PGE2, which might inhibit
NF-κB activity.36,40,41) These observations indicate that reactive
oxygen species are related to inammatory gene expression
though the NF-κB signaling pathway. Recently, violaxanthin
was reported to have strong antioxidant properties in oxidative
stress and function as a chain breaking antioxidant in lipid
peroxidation.20) Therefore, the antioxidant ability of violaxan-
thin may be originated from inhibition of iNOS and COX-2
expression.
In summary, we suggested that LPS stimulated RAW 267.4
via the TLR4-ERK/ NF-κB in the pro-inammatory signaling
pathway, and violaxanthin effectively inhibited these path-
ways. Taken together, our results revealed that violaxanthin
isolated from C. ellipsoidea can be a favorable candidate for
the treatment of inammatory disorders, and the anti-inam-
matory activity of violaxanthin may be based on its ability
to inhibit the expression of iNOS and COX-2 via inactivation
with NF-κB. Therefore, violaxanthin, a nonsynthetic natural
product, may serve as a safe and effective anti-inammatory
agent, which could be used for therapeutic purposes.
Acknowledgements This research was supported by the
Grant of No. RTI05-01-02 from the Regional Technology In-
novation Program of the Ministry of Knowledge Economics
(MKE). W. Soontornchaiboon was the recipient of a graduate
fellowship provided by Brain Korea (BK21) program spon-
sored by the Ministry of Education, Science and Technology,
Republic of Korea.
REFERENCES
1) Henderson B, Poole S, Wilson M. Bacter ial moduli ns: a novel class
of vir ulence factors which cause host tissue pathology by inducing
cytokine synthesis. Microbiol. Rev., 60, 316–341 (1996).
2) Esposito E, Cuzzocrea S. The role of nitric oxide sy nthases i n lung
inammation. Curr. Opin. Inve stig. Drugs, 8, 899 –909 (2007).
3) Stuhlmüller B, Unget hüm U, Scholze S, Martinez L, Backhaus M,
Kraetsch HG, Kinne RW, Burmester GR. Identication of known
and novel genes in activated monocytes from patients with rheuma-
toid a rth ritis. Arthritis Rheum ., 43, 775–790 (2000).
4) Hi rose M, Ishihara K, Saito A, Nakagawa T, Yamada S, Okuda K.
Expression of cytokines and inducible nitric oxide synthase in in-
amed gingival tissue. J. Periodontol., 72, 590–597 (2001).
5) Blant z RC, Munger K. Role of nitr ic oxide in i nammatory condi-
tions. Nephron, 90, 373 –378 (2002).
6) Mur akami A, Ohigashi H. Targeting NOX, INOS and COX-2 in in-
ammatory cells: chemoprevention using food phytochemicals. Int.
J. Cancer, 121, 2357–2363 (2007).
7) Zeilhofer HU, Brune K. Analgesic strategies beyond the inhibition
of cyclooxygenases. Trends Pharmacol. Sci., 27, 467–474 (2006).
8) Jachak SM. PGE synthase in hibitors as an alter native to COX-2
inhibitors. Curr. Opin. Investig. Drugs, 8, 411–415 (2007).
9) Itoh K, Udagawa N, Kobayash i K, Suda K, Li X, Takami M, Oka-
hashi N, Nishihara T, Takahashi N. Lipopolysaccharide promotes
the survival of osteoclasts via Toll-like receptor 4, but cy tokine pro-
duction of osteoclasts in response to lipopolysaccha ride is different
from that of macrophages. J. Immunol., 170, 3688–3695 (2003).
10) Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev., 18,
2195–2224 (2004).
11) Gouveia L, Raymundo A, Batista AP, Sousa I, Empis J. Chlorella
vulgaris and Haematococcus pluviales biomass as colouring and
antioxidant in food emulsions. Eur. Food Res. Technol., 222, 362–
367 (2006).
12) Hagen C, Braune W, Vogel K, Hä der PP. Functional aspects of sec-
ondar y carotenoids in Haematococcus lacust ris (Girod) ROSTAFINSK I
(Volvocales). V. Inuences on photomovement. Plant Cell Environ.,
16, 991–995 (1993).
13) Taylor CB. Control of cyclic carotenoid biosynthesis: no lutein, no
problem! Plant Cell, 8, 1447–1450 (1996).
14) Raja R, Hemaiswarya S, Rengasamy R. Exploitation of Dunaliella
for β-carotene production. Appl. Microbiol. Biotechnol., 74, 517–523
(2007).
15) Rao AR, Sarada R, Ravishankar GA. Stabilization of astaxanthin
in edible oils and its use as an antioxidant. J. Sci. Food Agric., 87,
957–965 (2007).
16) Del Campo JA, Moreno J, Rodríguez H, Vargas M A, Rivas J, Guer-
rero MG. Carotenoid content of chlorophycean microalgae: factors
determining lutein accumulation in Muriellopsis sp. (Chlorophyta).
J. Biotechnol., 76, 51–59 (200 0).
17) Chihara M, Murano M. An Illustrated Guide to Marine Plankton in
Japan. Tokai Univer siry Press, Tokyo, p. 1574 (1997).
18) Cha KH, Koo SY, Lee DU. A ntiproliferative effects of carotenoids
extracted from Chlorella ellipsoidea and Chlorella vulgaris on
human colon cancer cells. J. Agric. Food Chem., 56, 10521–10526
(2008).
19) Kimura M, Rodriguez-Amaya DB. A scheme for obtai ning st an-
dards and HPLC quaticat ion of leafy vegetable carotenoids. Food
Chem., 78, 389–398 (2002).
20) Fu H, Xie B, Ma S, Zhu X, Fan G, Pan S. Evaluation of antioxidant
activit ies of principal carotenoids available in water spinch (Ipo-
moea aquatica). J. Food Compost. Anal., 24, 288–297 (2011).
21) Davies BH. Analysis of carotenoid pigments. Chem. Biochem. Plant
Pigments. 1965, 489–532 (1965).
22) Rodriguez-Garcia I, Guil-Guerrero JL. Evaluation of the anti-
oxidant activity of the three microalgal species for use as dietary
supplements and in the preservation of foods. Food Chem., 108,
1023–1026 (2008).
23) Acemoglu M, Uebelhar t P, Rey M, Eugster CH. Synthese von en-
antiomerenreinen Violaxa nthinen und verwa ndten Verbindungen.
Helv. Chim. Acta, 71, 931–956 (1988).
24) rki-Fisher E, Buchecker R, Eugster CH, Englert G, Noack K,
Vecchi M. Absolute conguration of a nthra xanthin, cis-arithra-
xanthin and of the stereoisomeric mutatoxanthins. Helv. Chim.
Acta, 65, 2198–2211 (1982).
25) Moss GP. Carbon-13 NM R spectra of carotenoids. Pure Appl.
Chem., 47, 97–102 (1976).
1144 Vol. 35, No. 7
26) Leiper J, Vallance P. Biological signicance of endogenous methyl-
argin ines that inhibit nitric oxide synthases. Cardiovasc. Res., 43,
542–548 (1999).
27) Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inammatory
drugs as anticancer agents: mechanistic, pharmacologic, and clinical
issues. J. Natl. Cancer Inst., 94, 252–266 (2002).
28) Br unn GJ, Bungum MK, Johnson GB, Platt JL. Conditional signal-
ing by Toll-like receptor 4. FASEB J., 19, 872– 874 (2005).
29) MacMicking J, Xie QW, Nathan C. Nitric oxide and macrophage
function. Annu. Rev. Immunol., 15, 323–350 (1997).
30) Baeuerle PA, Henkel T. Function and activation of NF-kappaB in
the immune system. Annu. Rev. Immunol., 12, 141–179 (1994).
31) Baldwin AS. Control of oncogenesis and cancer therapy resistance
by the tra nscription factor N F-kappaB. J. Clin. Invest., 107, 241–246
(2001).
32) Guslandi M. Nitr ic oxide and inammatory bowel diseases. Eur. J.
Clin. Invest., 28, 904–907 (1998).
33) Moncada S, Palmer R M, Higgs EA. Nitric oxide: physiolog y,
pathophysiology, and pharmacology. Pharmacol. Rev., 43, 109 –142
(1991).
34) Cherng SC, Cheng SN, Tarn A, Chou TC. Anti-inam matory activ-
ity of c-phycocyanin in lipopolysaccha ride-stimulated RAW 264.7
macrophages. Life Sci., 81, 1431–1435 (2007).
35) Dinarello CA. Cytokines as endogenous pyrogens. J. Infect. Dis.,
179 (Suppl. 2), S294–S304 (1999).
36) Shao DZ, Lin M. Platonin inhibits LPS-induced NF-kappaB by pre-
venting activation of Akt and IKKbet a in human PBMC. Inamm.
Res., 57, 601–606 (2008).
37) Bai SK, Lee SJ, Na HJ, Ha KS, Han JA, L ee H, Kwon YG, Chung
CK, Kim YM. β-Ca rotene inh ibits inammator y gene expression in
lipopolysaccharide-stimulated macrophages by suppressing redox-
based NF-kappaB activation. Exp. Mol. Med., 37, 323–334 (2005).
38) Ra MM, Shafaie Y. Dieta ry lutein modulates inducible nitric oxide
synthase (iNOS) gene and protein expression in mouse macrophage
cells (RAW 264.7). Mol. Nutr. Food Res., 51, 333–340 (2007).
39) Heo SJ, Yoon WJ, Kim KN, Ahn GN, Kang SM, Kang DH, Affan
A, Oh C, Jung W K, Jeon YJ. Evaluation of a nti-inammatory effect
of fucoxanthin isolated from brown algae in lipopolysacchar ide-
stimulated R AW 264.7 macrophages. Food Chem. Toxicol., 48,
2045–2051 (2010).
40) Lee SJ, Bai SK, Lee K S, Nam koong S, Na HJ, Ha KS, Han JA, Yi m
SV, Chang K, Kwon YG, Lee SK, Kim YM. Astaxanthin inhibits
nitric oxide production and inammatory gene expression by sup-
pressing I(κ)B kinase-dependent NF-kappaB activation. Mol. Cells,
16, 97–105 (2003).
41) Heiss E, Herhaus C, Klimo K, Bartsch H, Gerhäu ser C. Nuclear
factor κB is a molecular t arget for sulforaphane-mediated anti-
inammator y mechanisms. J. Biol. Chem., 276, 32008–32015
(2001).
... They have been studied as green energy generators [1]; important food sources for humans and animals [2]; unparalleled feed for aquaculture [3]. Microalgae are a promising source of pharmacologically active compounds with potential therapeutic applications, showing anticancer, anti-inflammatory, antiviral, antifungal, and antibacterial properties [4][5][6]. Extensive research on marine microalgae has led to the identification of over 15,000 bioactive molecules, including fatty acids, sterols, phenolic compounds, terpenes, enzymes, polysaccharides, alkaloids, toxins, and carotenoids [7]. Among the natural antimicrobial agents derived from microalgae are fatty acids, indoles, acetogenins, phenols, terpenes, and volatile halogenated hydrocarbons [8]. ...
Article
Full-text available
Green algae of the genus Coelastrella have attracted the attention of scientists due to their rich biochemical composition and potential for application in phytomedicine. The present study investigated the influence of light on the bioactive capacity of extracts from the Bulgarian strain of the green microalgae Coelastrella sp. BGV. Three LED lights were examined—red/blue (C1), blue (C2), and control white light (C3). The respective ethanol extracts were analyzed for the total content of phenolic antioxidants. The antimicrobial activity was tested using the disk-diffusion method against 10 microorganisms. The antiproliferative and cytotoxic effects on cervical carcinoma HeLa and hepatocellular carcinoma HepG2 cell lines, as well as non-tumorigenic embryonal fibroblasts BALB/3T3 control, were evaluated using a cell viability assay. The overall results highlighted blue light as a factor enhancing the antioxidant, antibacterial, and cytotoxic activities of the C2 microalgal extract. Additionally, the investigated mechanism of the antitumor activity revealed a proapoptotic effect. In contrast, the C1 extract exhibited weaker activity and selectivity, while the C3 extract was the least active but demonstrated high cytotoxic selectivity. This study could contribute to expanding knowledge about the high biological potential of green microalgae and the development of biotechnological approaches for its regulation.
... In goat's beard foliage, concentrations of key carotenoids (CA-Lut, CA-βCar, CA-Vio, CA-Neo) were also notably higher than those found in red lettuce. These CAs are powerful antioxidants that exhibit anti-aging [50], anti-bacterial [51], anti-cancer [52], antiobesity [53], anti-inflammatory [54], and chemo-preventive [55] activities. Of the key CAs, CA-Lut was the most abundant (101.36 ± 1.20 µg/g FW) CA in goat's beard foliage, followed by CA-βCar (65.52 ± 3.02 µg/g FW), CA-Vio (55.92 ± 1.92 µg/g FW), and CA-Neo (30.21 ± 0.89 µg/g FW) ( Table 1). ...
Article
Full-text available
Green leafy vegetables are rich in lipophilic metabolites such as carotenoids, phytosterols, tocopherols, and fatty acids, known for their significant health benefits. Goat’s beard (Aruncus dioicus var. kamtschaticus), a wild leafy vegetable native to Ulleungdo Island, South Korea, is reported to possess various biological activities and bioactive compounds. However, the content and profiles of lipophilic metabolites, especially carotenoids, have not been reported. This study investigated the composition of lipophilic metabolites in the foliage of goat’s beard using liquid chromatography–diode-array detection–mass spectrometry, gas chromatography–mass spectrometry, and gas chromatography–flame ionization detection. Five carotenoids (violaxanthin, neoxanthin, lactucaxanthin, lutein, β-carotene) and α-tocopherol were identified and quantified using liquid chromatography–diode-array detection–mass spectrometry. Lactucaxanthin, previously discovered in lettuce, was identified for the first time in goat’s beard foliage, with a higher concentration (45.42 ± 0.80 µg/g FW) compared to red lettuce (19.05 ± 0.67 µg/g FW). Furthermore, total carotenoids and α-tocopherol contents were higher in goat’s beard than in red lettuce. Gas chromatography–mass spectrometry analysis showed the presence of three phytosterols, namely, campesterol (3.53 ± 0.20 µg/g FW), stigmasterol (65.30 ± 4.87 µg/g FW), and β-sitosterol (89.54 ± 2.46 µg/g FW). Gas chromatography–flame ionization detection analysis revealed the presence of five essential fatty acids, with α-linolenic acid (57.03 ± 0.47%) being the most abundant, contributing to a favorable polyunsaturated FA/saturated FA ratio. These findings underscore the nutritional potential of a goat’s beard, suggesting its promising use in dietary supplements and the commercial extraction of valuable lipophilic antioxidants, particularly lactucaxanthin, for nutraceuticals and functional foods.
Article
Full-text available
Nannochloropsis gaditana is well known for its potential for biofuel production due to its high lipid content. Numerous omics and biochemical studies have explored the overall molecular mechanisms underlying the responses of Nannochloropsis sp. to nutrient availability, primarily focusing on lipid metabolism. However, N. gaditana is able to synthesize other valuable products such as carotenoids, including violaxanthin, which has various biological functions and applications. In this study, we comparatively investigated the physiological, biochemical, and molecular responses of N. gaditana to nitrogen and phosphorus limitation, examining biomass production, photosynthetic activity, lipid, chlorophyll, and carotenoids content, and RNA-seq data. Nitrogen limitation decreased photosynthetic activity, chlorophyll content, and biomass production but increased lipid content. Phosphorus limitation substantially increased carotenoids content, with violaxanthin productivity of 10.24 mg/L, 3.38-fold greater than under the control condition, with little effect on biomass production or photosynthetic function. These results were generally consistent with the gene expression pattern observed in transcriptomic analysis. This integrated analysis shows that phosphorus limitation can be an economically competitive solution by enhancing valuable carotenoids while maintaining lipid and biomass production in N. gaditana.
Article
Full-text available
In Portugal, grapevine leaves are generally treated as agro-industrial waste, despite being rich in bioactive compounds that offer benefits to human health. This study compiles the most relevant and current data on the phytochemical composition and bioactive properties of grape leaves from both red and white varieties cultivated in the country. These by-products are abundant in flavonoid and non-flavonoid phenolic compounds, such as flavonols, derivatives of hydroxycinnamic acids, carotenoid pigments, and chlorophylls, as well as fatty acids, which have scientifically proven antioxidant, antimicrobial, anti-inflammatory, antidiabetic, cardio-, neuro- and hepatoprotective properties, among others. The combination of these beneficial properties, along with the low toxicity of their compounds, makes grapevine leaves a by-product with great potential for use in the food, pharmaceutical, and cosmetic industries. The key challenge is to develop sustainable methods to reintegrate this by-product into the supply chain, in alignment with the sustainability goals of the 2030 Agenda.
Chapter
In today’s fast-paced and image-focused world, the importance of personal appearance and personal care has increased significantly. As a result, there has been a surge in demand for cosmetic products. In particular, there is a growing interest in skincare products that contain natural ingredients. Seaweed, a diverse group of marine algae, has gained significant attention in recent years as a versatile and sustainable resource with numerous potential applications in the skincare and cosmeceutical industries. Seaweed, rich in bioactive compounds such as polysaccharides, polyphenols, vitamins, minerals, and essential fatty acids, offers a unique blend of functional ingredients for skin health. These compounds exhibit a wide range of beneficial properties, including moisturizing, antioxidant, anti-inflammatory, anti-photodamage, and anti-aging effects. Seaweed-based formulations have demonstrated promise in addressing various skin conditions, including acne, psoriasis, eczema, and premature aging, making them valuable assets in dermatological treatments. Moreover, the utilization of seaweed in cosmeceuticals has gained popularity as a sustainable and eco-friendly alternative to synthetic ingredients. Seaweed extracts have been incorporated into a variety of skincare products, including cleansers, moisturizers, masks, and serums. These compounds provide hydration, improve skin elasticity, reduce the appearance of fine lines and wrinkles, and promote a more youthful and radiant complexion. This chapter explored the potential skincare attributes inherent in seaweed-derived bioactive compounds and extracts as cosmeceutical and dermatological ingredients. In addition, their various skin-beneficial properties and potential roles in skincare were also discussed based on scientific literature.
Article
Microalgae and cyanobacteria are a rich source of carotenoids that are well known for their potent bioactivities, including antioxidant, anti-cancer, anti-proliferative, anti-inflammatory, and anti-obesity properties. Recently, many interests have also been focused on the biological activities of these microalgae/cyanobacteria-derived carotenoids, such as fucoxanthin and β-carotene potential to be the salutary nutraceuticals, on treating or preventing human common diseases (e.g., cancers). This is due to their special chemical structures that demonstrate unique bioactive functions, in which the biologically active discrepancies might attribute to the different spatial configurations of their molecules. In addition, their abundance and bioaccessibilities make them more popularly applied in food and pharmaceutical industries, as compared to the macroalgal/fungal-derived ones. This review is focused on the recent studies on the bioactivities of fucoxanthin and some carotenoids derived from microalgae and cyanobacteria in relationship with human health and diseases, with emphasis on their potential applications as natural antioxidants. Various biotechnological approaches employed to induce the production of these specific carotenoids from the culture of microalgae/cyanobacteria are also critically reviewed. These well-developed and emerging biotechnologies present promise to be applied in food and pharmaceutical industries to facilitate the efficient manufacture of the bioactive carotenoid products derived from microalgae and cyanobacteria.
Article
Carotenoids are tetraterpene pigments that are an essential part of the human diet and have a major impact on human health. Carotenoids possess some antioxidant, cytoprotective, photoprotective, and many other properties, enabling them to play their role against various diseases such as cancer, diabetes, cardiovascular diseases, obesity, and neurodegenerative disorders. This article comprehensively reviews carotenoids and their chemical characteristics, distribution, and metabolism inside human organisms. The data from many studies show their impact on cell metabolism, the induction of intercellular communication via gap junctions, their influence on the cell cycle, and the production of many substances leading to changes in signalling pathways. Moreover, the review attempted to provide an overview of how their various functions affect humans in general. Additionally, we provide a brief description of their potential negative effects. Understanding these interactions and recognising the respective roles of carotenoids may strongly influence a diagnostic workup.
Article
Full-text available
This review study highlights the importance of loquat (Eriobotrya japonica Lindl.) in terms of its nutritional, pharmaceutical, and nutraceutical value. The entire plant, including its seeds, leaves, flowers, fruits, and peel, contains a wide range of bioactive compounds, such as phenolics, carotenoids, triterpenic acids, and organic acids. These compounds exhibit a wide range of beneficial properties such as fighting cancer, reducing inflammation, managing diabetes, combating viruses, preventing mutations, inhibiting nitrosamine formation, killing harmful microorganisms, lowering blood sugar levels, inducing cell death, and protecting the liver. The extraction and separation of such compounds will greatly enhance and expand its potential. Furthermore, the waste generated from the seeds and peel can be effectively used for submerged and solid state biomass production.
Article
Full-text available
Human cognition fundamentally depends on memory. Alzheimer’s disease exhibits a strong correlation with a decline in this factor. Phosphodiesterase-4 B (PDE4B) plays a crucial role in neurodegenerative disorders, and its inhibition is one of the promising approaches for memory enhancement. This study aimed to identify secondary metabolites in white cabbage, coffee, and red onion extracts and identify their molecular interaction with PDE4B by in silico and in vitro experiments. Crushed white cabbage and red onion were macerated separately with ethanol to yield respective extracts, and ground coffee was boiled with water to produce aqueous extract. Thin layer chromatography (TLC)–densitometry was used to examine the phytochemicals present in white cabbage, coffee, and red onion extracts. Molecular docking studies were performed to know the interaction of test compounds with PDE4B. TLC-densitometry analysis showed that chlorogenic acid and quercetin were detected as major compounds in coffee and red onion extracts, respectively. In silico studies revealed that alpha-tocopherol (binding free energy (∆Gbind) = −38.00 kcal/mol) has the strongest interaction with PDE4B whereas chlorogenic acid (∆Gbind = −21.50 kcal/mol) and quercetin (∆Gbind = −17.25 kcal/mol) exhibited moderate interaction. In vitro assay showed that the combination extracts (cabbage, coffee, and red onion) had a stronger activity (half-maximal inhibitory concentration (IC50) = 0.12 ± 0.03 µM) than combination standards (sinigrin, chlorogenic acid, and quercetin) (IC50 = 0.17 ± 0.03 µM) and rolipram (IC50 = 0.15 ± 0.008 µM). Thus, the combination extracts are a promising cognitive enhancer by blocking PDE4B activity.
Article
Full-text available
The transcription factor NF-kappaB has been the focus of intense investigation for nearly two decades. Over this period, considerable progress has been made in determining the function and regulation of NF-kappaB, although there are nuances in this important signaling pathway that still remain to be understood. The challenge now is to reconcile the regulatory complexity in this pathway with the complexity of responses in which NF-kappaB family members play important roles. In this review, we provide an overview of established NF-kappaB signaling pathways with focus on the current state of research into the mechanisms that regulate IKK activation and NF-kappaB transcriptional activity.
Article
Cytokines are a diverse group of proteins and glycoproteins which have potent and wide-ranging effects on eukaryotic cell function and are now recognized as important mediators of tissue pathology in infectious diseases. It is increasingly recognized that for many bacterial species, cytokine induction is a major virulence mechanism. Until recent years, the only bacterial component known to stimulate cytokine synthesis was lipopolysaccharide (LPS). It is only within the past decade that it has been clearly shown that many components associated with the bacterial cell wall, including proteins, glycoproteins, lipoproteins, carbohydrates, and lipids, have the capacity to stimulate mammalian cells to produce a diverse array of cytokines. It has been established that many of these cytokine-inducing molecules act by mechanisms distinct from that of LPS, and thus their activities are not due to LPS contamination. Bacteria produce a wide range of virulence factors which cause host tissue pathology, and these diverse factors have been grouped into four families: adhesins, aggressins, impedins, and invasins. We suggest that the array of bacterial cytokine-inducing molecules represents a new class of bacterial virulence factor, and, by analogy with the known virulence families, we suggest the term "modulin" to describe these molecules, because the action of cytokines is to modulate eukaryotic cell behavior. This review summarizes our current understanding of cytokine biology in relation to tissue homeostasis and disease and concisely reviews the current literature on the cytokine-inducing molecules produced by gram-negative and gram-positive bacteria, with an emphasis on the cellular mechanisms responsible for cytokine induction. We propose that modulins, by controlling the host immune and inflammatory responses, maintain the large commensal flora that all multicellular organisms support.
Article
beta-Carotene has shown antioxidant and anti-inflammatory activities; however, its molecular mechanism has not been clearly defined. We examined in vitro and in vivo regulatory function of a-carotene on the production of nitric oxide (NO) and PGE2 as well as expression of inducible NO synthase (iNOS), cyclooxygenase-2, TNF-alpha, and IL-1 beta. beta-Carotene inhibited the expression and production of these inflammatory mediators in both LPS-stimulated RAW264.7 cells and primary macrophages in a dose-dependent fashion as well as in LPS-administrated mice. Furthermore, this compound suppressed NF-kappa B activation and iNOS promoter activity in RAW264.7 cells stimulated with LPS. (beta-Carotene blocked nuclear translocation of NF-kappa B p65 subunit, which correlated with its inhibitory effect on I kappa B alpha phosphorylation and degradation. This compound directly blocked the intracellular accumulation of reactive oxygen species in RAW264.7 cells stimulated with LPS as both the NADPH oxidase inhibitor diphenylene iodonium and antioxidant pyrrolidine dithiocarbamate did. The inhibition of NADPH oxidase also inhibited NO production, iNOS expression, and iNOS promoter activity. These results suggest that acarotene possesses anti-inflammatory activity by functioning as a potential inhibitor for redox-based NF-kappa B activation, probably due to its antioxidant activity.
Article
The '3C-NMR spectrum of j3-carotene has been assigned using data from deuterium labelled samples, and cis vitamin A. A study of methyl f3-apo carotenoates is consistant withthis result. Spectra of derivatives of 13-carotene, such as zeaxanthin, isozeaxanthin, violaxanthin and alloxanthin, have been analysed. The stereochemistry of lutein is deduced from its spectrum to be trans between the 3'-hydroxyl group and the polyene chain at C-6'. it is suggested that isomytiloxanthin has the alkyl groups at C-5 and C-6 of the cyclohexanone ring trans. Cis double bonds give characteristic changes in the spectrum compared with that of the corresponding trans compound violeoxanthin is shown to be the 9-cis isomer of violaxanthin. 13C—31P coupling over six bonds is observed with trans 13-C15 Wittig salt, but only over four bonds with the cis isomer. The 15,15'-cis-13-carotene spectrum suggests a revision of the assignment of the phytoene spectrum. Using the data from appropriate apo esters and other model compounds the spectra of capsorubin and azafrin are analysed. The absence of suitable model compounds as yet prevents a complete assignment of the fucoxanthin spectrum.
Article
Absolute Configuration of Antheraxanthin, ‘cis-Aritheraxanthin’ and of the Stereoisomeric Mutatdxanthins The assignement of structure 2 to antheraxanthin (all-E)-(3 S, 5 R, 6 S, 3′ R)-5,6-epoxy-5,6-dihydro-β,β-carotene-3,3′-diol and of 1 to ‘cis-antheraxanthin’ (9Z)-(3 S, 5 R, 6 S, 3′ R)-5,6-epoxy-5,6-dihydro-β,β-carotene-3,3′-diol is based on chemical correlation with (3 R, 3′ R)-zeaxanthin and extensive 1H-NMR. measurements at 400 MHz. ‘Semisynthetic antheraxanthin’ ( = ‘antheraxanthin B’) has structure 6. For the first time the so-called ‘mutatoxanthin’, a known rearrangement product of either 1 or 2, has been separated into pure and crystalline C(8)-epimers (epimer A of m.p. 213° and epimer B of m.p. 159°). Their structures were assigned by spectroscopical and chiroptical correlations with flavoxanthin and chrysanthemaxanthin. Epimer A is (3 S, 5 R, 8 S, 3′ R)-5,8-epoxy-5,8-dihydro-β,β-carotene-3,3′-diol (4; = (8 S)mutatoxanthin) and epimer B is (3 S, 5 R, 8 R, 3′ R)-5,8-epoxy-5,8-dihydro-β,β-carotene-3,3′-diol (3; = (8 R)-mutatoxanthin). The carotenoids 1–4 have a widespread occurrence in plants. We also describe their separation by HPLC. techniques. CD. spectra measured at room temperature and at − 180° are presented for 1–4 and 6. Antheraxanthin (2) and (9Z)-antheraxanthin (1) exhibit a typical conservative CD. The CD. Spectra also allow an easy differentiation of 6 from its epimer 2. The isomeric (9Z)-antheraxanthin (1) shows the expected inversion of the CD. curve in the UV. range. The CD. spectra of the epimeric mutatoxanthins 3 and 4 (β end group) are dissimilar to those of flavoxanthin/chrysanthemaxanthin (ε end group). They allow an easy differentiation of the C (8)-epimers.
Article
Syntheses of Enantiomerically Pure Violaxanthins and Related Compounds The epoxides 16 and ent ‐ 16 , prepared by Sharpless ‐ Katsuki oxidation of 15 in excellent yield and very high enantiomeric purity, were used as synthons for the preparation of (+)‐( S )‐didehydrovomifoliol (45) , (+)‐(6 S , 7 E , 9 E )‐abscisic ester 46 , (+)‐(6 S , 7 E , 9 Z )‐abscsic ester 47 , (−)‐(3 S , 7 E , 9 E )‐xanthoxin (49) , (−)‐(3 R , 7 E , 9 E )‐xanthoxin (50) , (3 S , 5 R , 6 S , 3′ S ,5′ R , 6′ S , all‐ E )‐violaxanthin (1) (3 R , 5 R ,6 S ,3′ R ,5′ R ,6′ S , all‐E)‐violaxanthin (55) and their (9 Z ) (see 53 , 57 ), (13 Z ) (see 54 , 58 ), and (15Z) (see 60 ) isomers. The novel violadione ( 61 ) was prepared from 1 by oxidation with DMSO/Ac 2 O. By base treatment, 61 was converted into violadienedione (62) , a potential precursor of carotenoids with phenolic end groups.